Company Monitoring Page for Amylin

latest headlines for company on cafepharma

Traders Call Bottom in Amylin
Seeking Alpha
Wed, 08/25/10 - 12:33 pm
Tags:
Amylin
How Long Can Amylin Pharmaceuticals Last?
Motley Fool
Wed, 08/18/10 - 07:33 am
Tags:
Amylin
Amylin Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Sat, 08/7/10 - 11:44 am
Tags:
Amylin, investors
Big Biotech: End of an Era
Seeking Alpha
Wed, 07/28/10 - 10:17 am
Tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Genentech, Dendreon, Genzyme, Gilead Sciences, GSK, Roche, Human Genome Sciences, Vertex Pharmaceuticals, Sanofi
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Tags:
Amylin, Bydureon, Byetta, diabetes, Novo Nordisk, Victoza, Merck, Januvia, Takeda, Actos, Onglyza, AstraZeneca
Into The Wild West: Biotech Trading
CNBC
Thu, 07/15/10 - 09:06 am
Tags:
biotech, Amylin, Genzyme, Human Genome Sciences
If Avandia falls, which diabetes meds fill the gap?
Fierce Pharma
Wed, 07/14/10 - 12:09 pm
Tags:
diabetes, GSK, Avandia, Actos, Takeda, Merck, Januvia, Novo Nordisk, Victoza, Eli Lilly, Byetta, Amylin, Onglyza, AstraZeneca, Bristol-Myers Squibb
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
Tags:
diabetes, Orexigen, Contrave, Avandia, GSK, Merck, Eli Lilly, Amylin, Novo Nordisk, JNJ, MannKind, Afrezza
Amylin's New Diabetes Drug Well Tolerated By Sufferers
CNBC
Mon, 06/28/10 - 02:59 pm
Tags:
Amylin, diabetes, Bydureon, type 2 diabetes
Improvement in Beta-Cell Function Observed After Three Years of BYETTA(R) Therapy: Data Presented at ADA 2010
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:56 am
Tags:
Eli Lilly, Amylin, Byetta, diabetes, type 1 diabetes
Meta-Analysis of SYMLIN(R) Clinical Data Showed No Increased Risk of Cardiovascular Adverse Events Associated With SYMLIN Treatment in Patients With Type 2 Diabetes
Yahoo/PR NewsWire
Sun, 06/27/10 - 10:54 am
Tags:
Symlin, Amylin, diabetes, type 1 diabetes
Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs
Trading Markets
Sat, 06/26/10 - 11:18 am
Tags:
Eli Lilly, Byetta, Amylin, diabetes
Roche’s Taspoglutide Works Better Than Lantus, Byetta in Trials
BusinessWeek
Sat, 06/26/10 - 10:29 am
Tags:
Roche, taspoglutide, Sanofi, Eli Lilly, Amylin, Byetta, Merck, Januvia, diabetes
Diabetes drug makers gain ahead of conference
MarketWatch
Sat, 06/26/10 - 09:13 am
Tags:
Arca pharmaceutical index, MannKind, Amylin, Molecular Insight, diabetes
Drug Pipeline Pulse Check: Roche’s Stumble Boosts Amylin
Seeking Alpha
Thu, 06/24/10 - 10:11 am
Tags:
Roche, Amylin, diabetes, taspoglutide
Amylin Soars on Roche’s Diabetes Delay
Barron's
Sat, 06/19/10 - 12:55 pm
Tags:
Amylin, Roche, type 2 diabetes, Bydureon
Heavy Call Selling Seen on Amylin Pharma (AMLN)
benzinga
Sat, 06/19/10 - 12:32 pm
Tags:
Amylin, investors
Amylin, Alkermes gain ground on Roche drug delay
Yahoo/AP
Fri, 06/18/10 - 11:28 am
Tags:
Roche, Amylin, Alkermes, diabetes, taspoglutide
Amylin Drug Fails To Beat Generic
Forbes
Tue, 06/15/10 - 12:36 pm
Tags:
generics, Amylin, metformin, diabetes, Bydureon, Byetta, Eli Lilly
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sun, 05/9/10 - 12:49 pm
Tags:
Bydureon, Amylin, Eli Lilly, Alkermes, type 2 diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.